PainReform Ltd. (PRFX) vs Redhill Biopharma Ltd. (RDHL)
PainReform Ltd. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. and Redhill Biopharma Ltd. are of similar size ($3.2M and $3.0M). Redhill Biopharma Ltd. has the higher net margin (25.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 7 metrics below, Redhill Biopharma Ltd. leads on 5 and PainReform Ltd. on 2.
Valuation
| Metric | PRFX | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.14 |
| P/S | n/m | 0.32 | 2.25 |
| P/B | 0.00 | n/m | 1.90 |
| Price to free cash flow | n/m | n/m | 16.54 |
| EV/EBITDA | 0.99 | n/m | 12.29 |
| EV/Sales | n/m | 0.30 | 2.56 |
| Earnings yield | (61,696.04%) | (122,133.34%) | (2.99%) |
| Free cash flow yield | (80,633.63%) | (909.75%) | 0.00% |
Profitability
| Metric | PRFX | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 35.16% | 53.94% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 25.20% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 0.00% | (0.40%) |
| Return on assets | 0.00% | 0.00% | (3.32%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack